Pfizer has blazoned its Omicron COVID-19 supporter is formerly in product as the variant has led to a massive increase in cases worldwide, counting for as numerous as 95 of new cases in the US (via OHS).

First reported in late November, in South Africa, Omicron has a large number of mutations, at least 30 of which are in the shaft protein, making it far more transmittable than former variants. In nearly every region it has spread, Omicron has snappily replaced Delta as the most dominant variant.

Despite the fact that vaccinated individualities are among those constricting Omicron, medical experts say vaccines are still the most effective way to shield off severe illness, hospitalization, and death.

The Food and Drug Administration (FDA) has authorized a follow-up shot of being vaccines from Pfizer, Moderna, and Johnson & Johnson as boosters to ameliorate impunity. While this strategy does ameliorate the efficacity of the vaccines against Omicron (via Zacks Equity Research), there have been calls to make a supporter specifically for the new variant.

According to Pfizer CEO Albert Bourla, Pfizer is formerly producing its Omicron-specific supporter, with plans to make it available in March.

“ This vaccine will be ready in March,” Bourla told CNBC’s Squawk Box. “ We (are) formerly starting manufacturing some of these amounts at threat.”

“ The stopgap is that we will achieve commodity that will have way, way better protection particularly against infections, because the protection against the hospitalizations and the severe complaint — it’s reasonable right now, with the current vaccines, as long as you’re having, let’s say, the third cure,” Bourla continued.

Still, and the Omicron-specific supporter does give better protection against infections, it could go a long way toward helping the world return to normal, If Bourla is correct. Although the current vaccine does a good job of guarding against severe illness and hospitalization, insulation and insulations are still a fact of life, indeed for vaccinated individualities who have come infected.